Siamak Daneshmand, MD, reports on recent controversies in treatment for non-muscle invasive bladder cancer (NMIBC) regarding chemotherapy options for reducing post-transurethral resection (TUR) recurrences and active surveillance for low-grade patients, as well as alternatives to cystectomy in high-grade patients.Read More
Sia Daneshmand, MD
University of Southern California
Los Angeles, California
Dr. Sia Daneshmand earned his medical degree at the University of California, Davis and completed his residency at the University of Southern California followed by a two-year fellowship in Urologic Oncology at the University of Southern California's Norris Comprehensive Cancer Center. He is currently the Associate Professor of Urology and serves as Director of Clinical Research at the University of Southern California and has extensive experience in the management of advanced kidney cancers and prostate cancer.
Articles by Sia Daneshmand, MD
Posted by Sia Daneshmand, MD | Dec 2017
Sia Daneshmand, MD, University of Southern California, Los Angeles, CA, gives an overview of...Read More